Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy

Bone marrow-derived mesenchymal stem cells (BMSCs) have emerged as a promising therapeutic strategy for cardiovascular disease. However, there is no evidence so far that BMSCs can heal pathological myocardial hypertrophy. In this study, BMSCs were indirectly cocultured with neonatal rat ventricular...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cells Transl Med
Autors principals: Cai, Benzhi, Tan, Xueying, Zhang, Yong, Li, Xingda, Wang, Xinyue, Zhu, Jiuxin, Wang, Yang, Yang, Fan, Wang, Baoqiu, Liu, Yanju, Xu, Chaoqian, Pan, Zhenwei, Wang, Ning, Yang, Baofeng, Lu, Yanjie
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2015
Matèries:
Tissue-Specific Progenitor and Stem Cells
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4675503/
https://ncbi.nlm.nih.gov/pubmed/26586774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2015-0032
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars